elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34376968-9D942AB4-866B-4272-890A-6D5EDF910E38
Q34376968-9D942AB4-866B-4272-890A-6D5EDF910E38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34376968-9D942AB4-866B-4272-890A-6D5EDF910E38
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies.
P2860
Q34376968-9D942AB4-866B-4272-890A-6D5EDF910E38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34376968-9D942AB4-866B-4272-890A-6D5EDF910E38
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e0e86d6a7d743676763b5a259b3a7ca0cf4fab4a
P2860
Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells.